Bellevue Group’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,910,639
| Closed | -$159M | – | 177 |
|
|
2022
Q4 | $159M | Sell |
5,910,639
-2,000
| -0% | -$53.9K | 2.11% | 12 |
|
|
2022
Q3 | $106M | Sell |
5,912,639
-7,000
| -0.1% | -$126K | 1.52% | 17 |
|
|
2022
Q2 | $73.6M | Buy |
5,919,639
+60,600
| +1% | +$753K | 1.04% | 30 |
|
|
2022
Q1 | $78M | Sell |
5,859,039
-310,000
| -5% | -$4.13M | 0.91% | 39 |
|
|
2021
Q4 | $96.1M | Buy |
6,169,039
+400,000
| +7% | +$6.23M | 0.99% | 34 |
|
|
2021
Q3 | $129M | Buy |
5,769,039
+500,000
| +9% | +$11.2M | 1.31% | 21 |
|
|
2021
Q2 | $120M | Buy |
5,269,039
+75,000
| +1% | +$1.71M | 1.17% | 23 |
|
|
2021
Q1 | $107M | Buy |
5,194,039
+390,000
| +8% | +$8.03M | 1.13% | 30 |
|
|
2020
Q4 | $133M | Sell |
4,804,039
-287,961
| -6% | -$7.95M | 1.52% | 21 |
|
|
2020
Q3 | $71.5M | Buy |
5,092,000
+445,000
| +10% | +$6.25M | 0.99% | 30 |
|
|
2020
Q2 | $95.8M | Sell |
4,647,000
-168,109
| -3% | -$3.47M | 1.36% | 16 |
|
|
2020
Q1 | $36.4M | Hold |
4,815,109
| – | – | 0.71% | 39 |
|
|
2019
Q4 | $74.7M | Hold |
4,815,109
| – | – | 1.18% | 25 |
|
|
2019
Q3 | $25M | Buy |
4,815,109
+905,000
| +23% | +$4.71M | 0.47% | 51 |
|
|
2019
Q2 | $35.4M | Buy |
+3,910,109
| New | +$35.4M | 0.6% | 42 |
|